Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Postoperative Complications 1Pancreatic Neoplasms 1

Interventions

Radiotherapy 4ferric carboxymaltose 3Exercise 3Surgical Procedures, Operative 2Sodium Chloride 2Sevoflurane 2Ropivacaine 2Propofol 2Preoperative Exercise 2Oxaliplatin 2Immunonutrition Diet 2Fluorouracil 2Fibrin Tissue Adhesive 2Ethanol 2Dexamethasone 2Counseling 2Bevacizumab 2vapreotide 1streptococcal preparation 722 1methyl N-acetylsibirosaminide 1ferrous sulfate 1Wound Closure Techniques 1World Health Organization oral rehydration solution 1Warm Ischemia 1Vitamin D 1Videotape Recording 1Video-Assisted Surgery 1Tranexamic Acid 1Tracheostomy 1Tidal Volume 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Postoperative Complications × vapreotide × Clear all
NCT00014651 2010-08-10

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Mayo Clinic

Phase 3 Terminated
Gastrointestinal

Pancreatic Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡